secwatch.observer — SEC 8-K summary
======================================

Issuer:     TALPHERA, INC. (TLPH)
CIK:        0001427925
Form:       8-K
Filed at:   2023-07-21T23:59:59+00:00
Accession:  0001437749-23-020383
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AcelRx raises ~$10M via private placement of common stock and warrants
----------------------------------------------------------------------

- Gross proceeds ~$10M from sale of 5.34M shares, pre-funded warrants for 2.01M shares, and Series A/B warrants for 7.35M shares each at $1.11 exercise price; combined price $1.36.
- Closing expected July 20, 2023; placement agent H.C. Wainwright receives 5.25% fee, expense reimbursement up to $100k, and $200k if warrant exercise proceeds exceed $9.5M.
- Registration rights agreement requires filing resale registration statement within 15 days, effectiveness within 90 days.
- Series A/B warrants exercisable immediately, 5-year term; Series A term shortens to 45 days upon FDA EUA for Niyad; Series B term shortens upon successful registrational trial for Niyad.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427925/000143774923020383/0001437749-23-020383-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427925/000143774923020383/acrx20230719_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-020383

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer